Ethosuximide

ATC N03AD01 · 7 markets · 67 records

Ethosuximide 7 markets · 67 records Forms

GB 42 records · 3 strengths

250 mgcapsuleEmeside 250mg/5ml syrup+3Epesri 250mg capsules、Zarontin、__no_trade__ also in US·AU·CA +1
250 mg/5 mLliquidEmeside 250mg/5ml syrup+3Epesri 250mg capsules、Zarontin、__no_trade__ also in US·AU
500 mg/5 mLliquidNo trade name

US 12 records · 2 strengths

250 mgcapsuleZarontin+1__no_trade__ also in GB·AU·CA +1
250 mg/5 mLliquidZarontin+1__no_trade__ also in GB·AU

AU 5 records · 4 strengths

250 mgcapsuleZarontin+1ZARONTIN ethosuximide 250mg capsule bottle also in GB·US·CA +1 unknown
250 mg/5 mLliquidZarontin also in GB·US
50 mg/mLliquidZARONTIN SYRUP ethosuximide 250mg/5mL oral liquid bottle unknown

Records without a stated strength · 1 Zarontin

CA 4 records · 2 strengths

250 mgcapsuleMAR-ETHOSUXIMIDE+2ODAN-ETHOSUXIMIDE、Zarontin also in GB·US·AU +1
50 mg/1 mLliquidZarontin

ES 1 records · 1 strengths

250 mgcapsuleETOSUXIMIDA FAES also in GB·US·AU +1

HK 1 records · 1 strengths

Records without a stated strength · 1 Ethosuximide

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	HK
250 mg capsule	No trade name Zarontin	No trade name Emeside 250mg/5ml syrup Epesri 250mg capsules +1 Zarontin	MAR-ETHOSUXIMIDE ODAN-ETHOSUXIMIDE Zarontin	Zarontin ZARONTIN ethosuximide 250mg capsule bottle	ETOSUXIMIDA FAES	not recorded
250 mg/5 mL liquid	No trade name Zarontin	No trade name Emeside 250mg/5ml syrup Epesri 250mg capsules +1 Zarontin	not recorded	Zarontin	not recorded	not recorded
500 mg/5 mL liquid	not recorded	No trade name	not recorded	not recorded	not recorded	not recorded
50 mg/1 mL liquid	not recorded	not recorded	Zarontin	not recorded	not recorded	not recorded
50 mg/mL liquid	not recorded	not recorded	not recorded	ZARONTIN SYRUP ethosuximide 250mg/5mL oral liquid bottle	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Zarontin	not recorded	Ethosuximide

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.